Sugi Predict

Sugi Predict / Compounds / SCHEMBL202597

SCHEMBL202597

SCHEMBL202597

C[C@H]1CCNc2nc3cnc4ccccc4c3n21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ HPGD P15428 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ POLB P06746 1/20 0.36
▸ JAK2 O60674 6/20 0.36
▸ JAK1 P23458 6/20 0.36
▸ MAPK10 P53779 1/20 0.35
▸ TLR7 Q9NYK1 1/20 0.35
▸ PDE10A Q9Y233 1/20 0.35
▸ GPR3 P46089 1/20 0.34
▸ LMNA P02545 2/20 0.34
▸ HTT P42858 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ NCOA3 Q9Y6Q9 1/20 0.34
▸ AURKA O14965 1/20 0.34
▸ PRKCA P17252 1/20 0.34
▸ KDR P35968 1/20 0.34
▸ PIK3CD O00329 1/20 0.33
▸ PIK3CA P42336 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL203764 0.87 CYP3A4 (0.36) KDM4EALDH1A1HPGDHSD17B10JAK2
SCHEMBL203276 0.87 CYP3A4 (0.36) KDM4EALDH1A1HPGDHSD17B10JAK2
SCHEMBL2743292 0.74 KDM4E (0.58) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL1773860 0.72 KDM4E (0.34) KDM4EJAK2JAK1TLR7GPR3
SCHEMBL1774815 0.71 ALDH1A1 (0.34) KDM4EALDH1A1POLBPDE10AGPR3
SCHEMBL2087803 0.69 LRRK2 (0.41) LRRK2
SCHEMBL14605232 0.68 JAK1 (0.69) JAK2JAK1AURKAPRKCAKDR
SCHEMBL14605231 0.68 JAK1 (0.69) JAK2JAK1AURKAPRKCAKDR
SCHEMBL14605096 0.68 JAK1 (0.56) JAK2JAK1
SCHEMBL202177 0.67 PDE10A (0.38) KDM4EALDH1A1HPGDHSD17B10POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088788-B2 Substituted fused[1,2] imidazo[4,5-c] ring compounds and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-01-03 — — US disclosed
US-8088788-B2 Substituted fused[1,2] imidazo[4,5-c] ring compounds and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-01-03 — — US disclosed
US-8088788-B2 Substituted fused[1,2] imidazo[4,5-c] ring compounds and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-01-03 — — US disclosed
US-20090221551-A1 SUBSTITUTED FUSED[1,2] IMIDAZO[4,5C] RING COMPOUNDS AND METHODS PFIZER INC. 2009-09-03 — — US disclosed
US-20090221551-A1 SUBSTITUTED FUSED[1,2] IMIDAZO[4,5C] RING COMPOUNDS AND METHODS PFIZER INC. 2009-09-03 — — US disclosed
US-20090221551-A1 SUBSTITUTED FUSED[1,2] IMIDAZO[4,5C] RING COMPOUNDS AND METHODS PFIZER INC. 2009-09-03 — — US disclosed
WO-2007106852-A2 SUBSTITUTED FUSED[1,2]IMIDAZO[4,5-C] RING COMPOUNDS AND METHODS COLEY PHARMACEUTICAL GROUP, INC. (US) 2007-09-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221551-A1 SUBSTITUTED FUSED[1,2] IMIDAZO[4,5C] RING COMPOUNDS AND METHODS IL2, IFNG, IL4 KDM4E 2419/4885ALDH1A1 979/4885HPGD 235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.